KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Guardant Health (GH) FCF Margin (2017 - 2026)

Guardant Health's FCF Margin history spans 9 years, with the latest figure at 19.28% for Q4 2025.

  • On a quarterly basis, FCF Margin rose 2204.0% to 19.28% in Q4 2025 year-over-year; TTM through Dec 2025 was 23.73%, a 1347.0% increase, with the full-year FY2025 number at 23.73%, up 1347.0% from a year prior.
  • FCF Margin hit 19.28% in Q4 2025 for Guardant Health, down from 17.26% in the prior quarter.
  • Over the last five years, FCF Margin for GH hit a ceiling of 17.26% in Q3 2025 and a floor of 99.95% in Q2 2022.
  • Historically, FCF Margin has averaged 49.59% across 5 years, with a median of 46.96% in 2022.
  • The widest YoY moves for FCF Margin: up 4575bps in 2021, down -5935bps in 2021.
  • Tracing GH's FCF Margin over 5 years: stood at 70.57% in 2021, then fell by -1bps to 71.03% in 2022, then surged by 39bps to 43.6% in 2023, then rose by 5bps to 41.32% in 2024, then soared by 53bps to 19.28% in 2025.
  • Business Quant data shows FCF Margin for GH at 19.28% in Q4 2025, 17.26% in Q3 2025, and 28.41% in Q2 2025.